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ABSTRACT
The National Aeronautics and Space Administration (NASA) is contemplating sending humans
to Mars and to the Moon for further exploration. Equipment designated for these extraterrestrial
bases will require testing in simulated Martian or lunar environments. The properties of
Hawaiian and San Francisco Mountain volcanic ashes make them suitable to be used in these
test environments as Martian and lunar dust simulants, respectively. The present toxicity study
was conducted to address NASA's concern about the health risk of dust exposures in the test
facilities. In addition, the results obtained on these simulants can be used to design a toxicity
study of actual moon dust and Martian dust, which will probably be available in a few years.
Respirable portions of lunar soil simulant (LSS) and Martian soil simulant (MSS) were
separated from their respective raw materials. These soil simulants, together- with fine titanium
dioxide (negative control for fibrogenesis in mice), and crystalline silica (positive control) were
each intratracheally instilled in saline to groups of 4 male mice (C57BL/6J, 2-3 months old) at
0.1 mg/mouse (LD) or lmg/mouse (HD). The lungs were harvested 7 or 90 days after the
single dust treatment for histopathological examination. Lungs of the LSS-LD groups on either
the 7- or 90-day study showed no evidence of inflammation, edema, or fibrosis. Clumps of
particles and an increased number of macrophages, visible in the lungs examined after 7 days,
were absent after- 90 days. The LSS-HD-7d group showed mild to moderate alveolitis with
neutrophilic and lymphocytic infiltration, and mild perivascular and peribronchiolar
inflammation. The LSS-HD-90d group showed signs of chronic inflammation: septal
thickening, mild perivascular and peribronchiolar inflammation, mild alveolitis and some
fibrosis. Foci of particle-laden macrophages (PLMs) were still visible. Lungs of the MSS-LD-
7d group revealed mild focal intraalveolar inflammation with neutrophilic and lymphocytic
infiltration, and mild perivascular and peribronchiolar inflammation. The MSS-LD-90d group
showed PLMs and scattered foci of mild fibrosis. The MSS-HD-7d group showed large foci of
PLMs, intraalveolar debris, mild to moderate focal alveolitis, and mild to moderate perivascular
and peribronchiolar inflammation. The MSS-HD-90d group showed focal chronic mild to
moderate alveolitis and fibrosis. To mimic the oxidative and reactive properties of Martian
surface dust in the test animals, groups of 4 mice were exposed to ozone (0.5 ppm for 3 hours)
prior to instillation of the MSS. Lung lesions in the MSS groups were more severe with the
ozone pretreatment. The 0 3-MSS-HD-90d group had wide spread intraalveolar debris, focal
moderate alveolitis and fibrosis. The results for the titanium dioxide and quartz controls were
consistent with the known pulmonary toxicity of these compounds. The overall severity of toxic
injury to the lungs was T10 2<LSS<MSS<MSS+0 3<quartz. In general, the toxic responses
increased with the increase of dust burden in the lung. Except for T10 2, the increased duration
of dust presence in the lung from 7 to 90 days transformed the acute inflammatory response to a
chronic inflammatory lesion.
Key Words: Pulmonary toxicity, intratracheal instillation, dust toxicity, Martian dust, lunar
dust, quartz, titanium dioxide, volcanic ash
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INTRODUCTION
NASA is considering returning to the Moon to establish a lunar outpost and sending humans to
explore Mars (Hoffman and Kaplan, 1997). Instruments and hardware destined for these
extraterrestrial bases must be tested in simulated Martian and lunar environments in NASA
laboratories. Hawaiian volcanic ash [designated as JSC Mars-1 (Allen et al., 1998)] and San
Francisco Mountain volcanic ash [designated as JSC-1 (McKay et al., 1994)], which have
mineral properties that resemble to those of Martian and lunar soils, respectively, are used for
the extraterrestrial environmental simulations (Glaser, 1992). Since the inhalation toxicity of
the extraterrestrial soils and the simulants has not been evaluated, NASA is concerned about the
health risk of dust exposures to workers in the Earth-based test facilities. Furthermore, toxicity
testing with simulants can provide guidance for designing experiments with actual lunar dust
and eventually Martian dust.
During the Apollo lunar landing, the moon dust particles encountered were described by the
crew as extremely fine (NASA, 1969). It stuck to spacesuits despite attempts to brush it off and
was brought into the lunar landing vehicles. After the spacecraft lifted off from the lunar
surface and zero gravity was reestablished, a large quantity of floating dust made breathing
difficult and impaired the visual acuity of the crew (NASA, 1970). Shortly after- lunar soil
samples were brought back to the Earth, NASA conducted comprehensive studies to determine
whether the soil contained extraterrestrial, biologically-active agents that could produce disease
or possessed "replicating agents" (Taylor et al., 1975; Benschoter et al., 1970; Holland and
Simmonds, 1973). Few investigations were done on toxicological properties, and the results
failed to reveal whether the dust is toxicologically hazardous (Holland and Simmonds, 1973).
The toxicity of lunar soil was also investigated by the Russians in mice (Kustov et al., 1974) and
rats (Belkin et al., 1983). These efforts have been summarized in a tome with the conclusion
that lunar soil caused fibrosis and other signs of pneumoconiosis (Kustov et al. 1989).
However, the studies contained considerable experimental deficiencies and unsupported
interpretations (see Discussion for details).
The present toxicity study was conducted on a simulated lunar soil (JSC-1) because test-facility
workers can be exposed to this material during earth-based engineering studies and because
NASA requires a successful study on a simulant before it will release a lunar dust sample for a
study. The material was mined from volcanic ash deposited in the San Francisco volcano field
near Flagstaff, AZ. The oxide composition of the simulant is a good match for mare soils
derived from lunar basalts. Both materials contain about 50% S10 2 ; other common soil oxides
(Al203, FeO, MgO, and CaO) account for another 42-45% (McKay et al., 1994). The particle
size distribution (average about 100 µm) of the simulant fits within the range of lunar samples
returned by Apollo missions (McKay et al., 1994). Dust particle fractionation conducted by
Lovelace Inhalation Research Institute (Albuquerque, NM) associated with the present study
showed that JSC-1 contained 1.1% dust with particle sizes at the respirable range.
Martian regolith is amorphous and chemically similar to Hawaiian volcanic ash. Martian soil
and the simulant both contain more than 30% silica (Allen et al., 1998). Besides silica, Fe 203 ,
which imparts the brown coloration to both the regolith and its simulant, together with Al203
account for another 30% of the total weight. Only 1% of the simulant is smaller than 5 pm. All
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compounds identified in the sample are in the form of oxides; none of them are heavy metals.
Gas-exchange experiments conducted by the Viking Martian lander biological instrument
showed evolution of oxygen when the Martian surface samples were humidified (Oyama and
Berdahl, 1977). According to these authors, the test results indicate that the reaction would
involve one or more reactive species of ozonides, superoxides, or peroxides; the most likely
candidates proposed were potassium, calcium, and sodium superoxides. More recent data led
investigators at the Jet Propulsion Laboratory (Pasadena, CA) to conclude that the highly
oxidizing substance that releases oxygen is an iron rich clay containing potassium iron tetroxide
(K2Fe"04) (Tsapin, 2000). All these species are extremely reactive and oxidative; thus,
inhalation exposures to Martian regolith would be expected to produce lesions in the lung
partially resembling those caused by powerful oxidants. Since oxidatively-activated Hawaiian
volcanic ash or the reactive iron oxide is not available, an ozone exposure of the mice followed
by an intratracheal instillation with the unactivated ash was included in the present study to
simulate the effects of the oxidative properties of Martian soil in the lung. Ozone was chosen
because its effects in the lung have been well characterized and that it was feasible to select a
dose that would produce no more than minimal tissue injury.
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MATERIALS AND METHODS
Simulated Martian and Lunar Dusts
The lunar soil simulant (JSC-1) was mined from a volcanic ash deposit in the San Francisco
volcano field near Flagstaff, AZ (McKay, 1994). The Martian soil simulant (JSC-Mars-1) was
obtained from the Mauna Kea volcano in Hawaii (Allen et al., 1998). About 1.1 kg LSS and
1.3 kg of MSS, provided by C. Allen of the NASA Office of Curator at the Johnson Space
Center (Houston, TX), were size-fractionated by Lovelace Respiratory Research Institute. The
raw material was placed in a DeVilbiss dry powder generator operated with compressed air at
20 psig; the output was then delivered to a 3-stage cyclone operated at 31 L/min (Smith et al.
1979). The median cut-off diameters were 5, 1.95, and 0.28 µm for the 3 stages. The particles
from second and third stages and the backup filter were collected and pooled for the present
study. The yields of these fine simulated lunar and Martian soil samples were 12.2 g (1.I %) and
5.2 g (0.4%), respectively; the mass median aerodynamic diameter (MMAD) of both soils was
less than 5 µm (Cheng, personal communication, 1998).
Particle Size Distribution Determination
Approximately 50 mg of the LSS or MSS was suspended in ca. 200 cc of distilled water and
placed into a reservoir chamber of a Microtrac X-100 Particle size analyzer (Microtrac, Inc.
Montgomeryville, PA). This tri-laser analytical unit was connected to a computer unit for data
acquisition and analysis. The instrument has a particle-size analytical range of 0.04 - 700 µm
separated into 120 channels. Timed ultrasonication, which is controlled by the computer, can be
generated in the reservoir chamber to ensure that the particles remain homogeneously
suspended. Particle size distributions of the LSS and MSS are shown in Figures IA and 1B,
respectively. The ultrasonicated lunar dust simulant showed a bimodal size distribution with
peaks at 1.1 and 3.0 microns. The ultrasonicated Martian dust simulant showed peaks at 3.0 and
108 microns, with the majority in the lower size range.
^ .	 ... .................	 .	 ................ 	
....	
_.... ................_._._..	 ..............__..........
X100	 „net
	 t r^zac -	 „^	 tear r sr	 s:^ - ^€ r^	 t•
Wimsi.>;:ttiaSedNe	 _TN'. ev
	
 
Ti-
. 
ag;«^c3.	 • x	 #are Si?aa^'^'^:ast	 m'	 4>:.,•	 xro:	 aao f£.S.pe.: 2'.
	
03:40	 R!.s i; 1
	
T%a	 06:13	 p	 tt. 1
F.a: :-::^	
.ufimsty	 ?... Hes	 acL'^	 'S .utlrt!sY:	 n'3,':	 y 
aa ass3kaxr`	 "<.S]> 10ti^C80480s: a 26:0 1103 Sd'a id`s
	
30scxui5:ttek	 mva39.36 19% a 170080$ a S85F t7g.d ei*a. 1'4.f
	
. C'69 30, • I G3' %1'S:+ a 803 E0 g6 4a% 0 f.5„	 'm{ a :.C50 20% x t :2 'Oti a 21.03 : 641 #A "u? Ei 4St ]0%at,.3a FAtixdR`9	 <3g 65A ,.4693 Ca 310.
^a 4517 '0"4a 1d32 Y0% x
 G3a8	 1	 cS a '..&b3 RYk a idtS *v^°A = 50dC	 i
s0 m f d]' SOk s 1 i2d FgY. = g..`.S:	 s1 r -242 511•11 x 4.5(p
 9%i a 175.E
	
: J	 i 100.0	 3	 . . I	.i	 ^	 I'^004
	
14	 100
eO.0
	
....)	 ^.11+	 ...__y	 .. ......
	
i..^	 I ^.	 0.R	 80.0	
__..	 ii S	 __	
_ -^---^ ! .",	 a.a
l	 I
70A	 -_ ._ ',, ..	 ..	
_.	 I _ . t-	1	 I	 i?S	 '	 1RA	 ^ {	 -	 ^	 +-1• 'i.___*
	
I	
,D
E00	 ..	 ...	 Y	 :.	 I	 {	 g.0	 bT.O	 ._^'
	
.....	 I	 .__	 { I	 8A
	
_{ 	 I	 {	 f	 li53.0
	
...	 {	 +^	 ,c0	 53A
	
-^	 I	 1 3 l
d0.a
	
I
 
44
sR.a
	
._	 L	 l	 r	 it	 RA	 {	 ^.e	 i	 ..{ +:	 SA
	
I^.	 I	 I^	 '	 {:t 20
10.0	 iR.0
0.010	 0:00IAM	 10.00	 100.0	 1000	 0010	 0100	 1.000
	 1000	 100.0	 1000
..._.. ..
•SVe (mc7a0s).'.......... .............._. _.__...............................................................................................^ 	 ..	 ...-..__..__--.__
	
-$IM ImICfd151
FIG. 1. Particle size distribution (mass %) of lunar soil simulant (A, right), and Martian soil
simulant (B, left) after ultrasonication in water.
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Titanium Dioxide and Crystalline Silica
The titanium dioxide sample, a product of Particle Information Services (Kingston, MA), had an
average particle diameter of 0.45 µm. Crystalline silica (quartz) (acid-washed Min-U-Sil-5) of
average size 5 µm was obtained from Pennsylvania Glass and Sand (Pittsburgh, PA).
Animals and Animal Husbandry
Male mice (C57BL/6J, 2 months old, ca. 20g), free of known rodent pathogens, were obtained
from Jackson Laboratory (Bar Harbor, ME). The animals were housed in groups of 4 in
polycarbonate cages (with HEPA air filters) in the AAALAC-accredited vivarium at the
Johnson Space Center (JSC). Animals were allowed to acclimatize at this facility (with a 12-
hour light-dark cycle) for at least one week before being used in the study. The mice were
freely provided with tap water and Purina Formulab Chow No. 50008 (Ralston Purina Co., St.
Louis, MO). They were cared for and used humanely according to NASA animal care and use
program guidelines.
Inhalation Exposure to Ozone
Those animals in the MSS study that required an ozone exposure were transported from JSC to the
University of Texas School of Public Health, a local university equipped with a 0.75 m 3 Laskin-type
stainless steel exposure chamber (Wahman, MD). The exposure procedure of Kirichenko et al.
(1996) was adopted. In brief, ozone was generated bypassing house air through an electrical ozone
generator (Model V5AR-237 ozonator, Ozone Research Equipment Corp, Phoenix, AZ); it was then
metered and mixed with house air before entering the chamber. A small air stream was pulled (2
L/min) from the chamber through Teflon tubing into a calibrated ozone monitor (Model 1003AH,
Dasibi Environmental Corporation, Glendale, CA). The monitor was calibrated shortly before the
present study by a laboratory at the US Environmental Protection Agency (Houston Regional
Office). After the chamber ozone concentration had been stabilized at about 0.5 ppm, six groups of
rnice (4 mice/group) were placed in the chamber. This exposure level was selected to produce no
more than minimal tissue injury. An ozone concentration reading was recorded every 10 minutes.
After a 3- hour- exposure to 0.51 ± 0.02 ppm of ozone, the animals were immediately returned to
JSC for dust instillation. This order of treatments was chosen because it allowed the dust instillation
to be carried out within 2-4 hours after the ozone exposure. If the order were to reverse, both
treatments could not be conducted on the same day because it would take a considerable amount of
time for the animals to recover from anesthesia, surgery, and fluid in lung, which was instilled with
the dust.
Intratracheal Instillation of Dust Samples
The mice were each anesthetized intraperitoneally with a cocktail of 150 µd of a ketamine (Ketaset,
Dodge Laboratory, Ford Dodge, IO) and xylazine (Rompun, Bayer, Shawnee Mission, KS) at a
dosage of approximately 80 and 16 mg/kg, respectively. After the animal was tagged with an ear
tag, the body weight was determined and the animal was secured on a slant plastic platform (about
45°). The trachea was exposed by a 1-cm incision on the ventral neck skin. All aliquot of 50-tt1 of
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freshly suspended and ultrasonicated dust in normal saline, containing 0.1 mg (LD) or 1 mg (HD)
dust, was intratracheally instilled (using 26-g needles) into the lung. For the saline and ozone-only
control animals, only saline was given. The incision was then stitched and swabbed with antiseptic
(povidone iodine). After the animals recovered from anesthesia, they were returned to the viviarium
and were observed daily until scheduled termination.
Collection of Lungs from Animals for Histopathological Study
Seven or 90 days after the dust treatment, the mice were each euthanized intraperitoneally with
an over dose of 30 µl of Nembutal sodium solution (ca. 400 mg/kg); body weights were
determined. The trachea was exposed and a catheter (a blunt 26-g needle) was inserted into and
tied to the trachea. Formalin (10%) in a neutral phosphate buffer (Fisher Scientific, Pittsburgh,
PA) was allowed to drip slowly into the lung in situ of the animal lying in supine position on a
75° platform. After perfusing for about 10 to 15 min, the trachea was tied and the lung was
removed from the chest cavity. The lung was placed in a glass vial containing 5 to 10 ml of the
same fixative solution. Each glass vial was assigned a number blind to the pathologists. The
lungs were fixed for at least 7 days before further processing.
Preparation of Lung Tissue Slides for Histopathological Examination
The formalin-fixed mouse lungs were embedded in paraffin, thin-sectioned coronally, and mounted
on glass microscope slides using standard histopathologic techniques. Sections were stained with
hematoxylin, eosin, van Gieson for elastin, and trichrorne dyes for connective tissue. One slide per
section per stain for each mouse was examined independently by three pathologists. A formatted
score sheet was used for grading intraalveolar, interstitial, vascular, and bronchiolar particles,
fibrosis, edema, and inflammation. The scores from the three pathologists were averaged.
Collection of'Blood for Cellular Autoimmunity Assay
For those mice in the 90-day study, before the lung was perfused with formalin, the abdominal
cavity of the animals was opened and a blood sample was collected from the descending aorta. The
blood was centrifuged at 1000 rpm and serum was collected and frozen. Antinuclear antibodies
(ANA) were analyzed according to the procedures described by Fritzler and Tan (1985). The
procedure involved indirect immunofluorescence microscopy on Hep-2 cells (Immuno Concepts,
Inc., Sacramento, CA) grown on Teflon-masked slides. The intensity of the fluorescence was
graded 0-4 and the results were analyzed by ANOVA followed by a non-parametric Kruskal-Wallis
test followed by a Nunn's test (to compare all columns). P < 0.05 was considered significant.
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RESULTS
Effects of Instilled Titanium Dioxide on the Lungs of Mice
After receiving a single intratracheal instillation of TiO 2
 (0.1 mg/mouse, LD), the lungs of the mice
killed 7 days after the treatment showed focal clumps of particles; some of the particles were inside
macrophages. There was no evidence of inflammation, edema, or fibrosis. For those animals killed
90 days after the dust treatment, the lungs had no identifiable particles and were completely normal
(Fig. 2A). This slide, which is indistinguishable from those of saline-treated controls, is used in this
manuscript for illustrating normal lung tissue histology.
When compared to the low-dose groups, the lungs of the high-dose (1 rng/rnouse) groups killed 7
day after the treatment showed larger focal clumps of particles; the HD-90d group had increased
numbers of alveolar macrophages but minimal tissue reaction (Fig. 2B).
Effects of Instilled Quartz on the Lungs of Mice
The lungs of the SiO ,)-LD-7d group showed focal clumps of particles and an increased number of
alveolar macrophages. Mild to moderate focal alveolar inflammation, mild focal perivascular and
peribronchiolar inflammation, neutrophilic and lymphocytic infiltration, and edema also were
observed. For those SiO-)-LD mice killed 90 days after the dust treatment, the lungs still had clumps
of particles and particle-laden macrophages (PLMs) in addition to mild inflammation and mild focal
fibrosis (Fig. 2C).
The lungs of the HD-7d group contained larger- focal clumps of particles and more macrophages
when they were compared with the lungs of the LD-7d group. In addition, the lung lesions were
more severe showing moderate to severe alveolitis, moderate focal perivascular and peribronchiolar
inflammation, and edema. For the high-dose group in the 90-day study, large clumps of PLMs were
still abundant in the lungs. The lungs also showed moderate alveolitis, moderate to severe focal
bronchiolar, perivascular, and peribronchiolar inflammation, necrosis, edema, and focally severe
fibrosis, strongly resembling bronchiolitis obliterans organizing pneumonia (Fig. 2D).
Effects of Instilled Lunar Soil Simulant (LSS) on the Lungs of Mice
The lungs of the LSS-LD-7d group showed the presence of focal clumps of particles and,
occasionally, macrophages (Fig. 3A). There was no evidence of inflammation, edema, or fibrosis.
At 90 days, particles were not observed and the tissue was also completely normal (Fig. 313).
For the HD-7d group, the lungs showed clumps of particles and macrophages, mild to moderate
alveolitis with neutrophilic and lymphocytic infiltration, and mild perivascular and peribronchiolar
inflammation (Fig. 3C). When examined 90 days after the dust treatment, foci of PLMs, mild
alveolitis, mild focal perivascular and peribronchiolar- chronic inflammation, and septal thickening
were visible (Fig. 3D).
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Effects of Instilled Martian Soil Simulant (MSS) on the Lungs of Mice
The lungs of MSS-LD-7d group revealed the presence of particles and macrophages; there was mild
focal intraalveolar debris, infiltration of neutrophils and lymphocytes, and perivascular and
peribronchiolar inflammation (Fig. 4A). At 90 days, PLMs and scattered foci of mild fibrosis were
detected (Fig. 4B).
Mice of the HD-7d group showed that the lungs had large foci of PLMs, mild focal alveolitis,
intraalveolar debris, and mild to moderate perivascular and peribronchiolar inflammation (Fig. 4C).
At 90 days, there were particle-laden macrophages, mild alveolitis, focal moderate inflammation,
and fibrosis (Fig. 41)).
Effects of Instilled MSS in the lungs of Ozone-pretreated Mice
A single 3-hour inhalation exposure to 0.51 ± 0.02 ppm ozone (followed by saline instillation)
produced no overt lung injury when examined 7 days after the exposure, but focal mild alveolitis
and peribronchiolar inflammation were noted 90 days after the exposure. When an ozone exposure
was followed by an intratracheal installation of MSS (0.1 mg or 1 mg/mouse), the lungs of the LD-
7d group showed the presence of foci of particles and an increase of macrophages. Focal mild
peribronchiolar inflammation and alveolitis were also visible (Fig. 5A). At 90 days, the lungs of the
03+MSS-LD mice revealed focal mild peribronchiolar inflammation, alveolitis, and fibrosis (Fig.
5B).
The 03+MSS-HD-7d group showed large foci of PLMs, focal moderate peribronchiolar
inflammation, alveolitis, intraalveolar debris, and early focal moderate to severe fibrosis (Fig. 5C).
The HD-90d group had wide spread intraalveolar debris, alveolitis, and focal moderate
inflammation and fibrosis (Fig. 51)).
Body Weight Changes after Instillation of the Dusts
There were no statistically significant differences in body weight gains between the exposed groups
and control groups terminated either on 7 or 90 days after instillation of the dusts. After 7 days the
group average body weight gains ranged from a low of —0.3 g (0.1 mg MSS) to +2.2 g (ozone
control group). After 90 days the weight gains ranged from 4.0 g to 6.4 g. The groups with the
lowest average body weight gains were the 0 3+MSS-HD (4.0 ±1.6 g), Si02-LD (4.6 ± 1.3 g), and
Si02-HD (4.9 ±0.7 g). These are among the groups that showed the most histopathological effects in
the lungs exposed to the dust for 90 days.
Determination of Antinuclear Antibodies in Sera of Dust-Treated Mice
In order to assess LSS and the other dusts for the potential of inducing cellular autoimmunity, ANA
fluorescence intensity of cells in sera collected from control (saline) mice and dust-treated mice
were determined and compared. Results of this screening showed that all dusts tested were capable
of increasing ANA (Figs. 6 and 7). However, the results from only those treated with low-dose LSS
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and high-dose silica were statistically significantly different from controls. Ozone-pretreatment
statistically significantly enhanced the ANA response in the 0.1-mg MMS group; the increase was
not significant in the 1-mg group. The reasons for the apparent lack of close-response in some of
these findings are not known. However, the lack of dose response in ANA studies also has been
observed by others.
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DISCUSSION
Appropriate intratracheal instillation doses were chosen based on information from Henderson et al.
(1995). Henderson reported that, in rats exposed by inhalation to 10 mg/m 3 of quartz or T102 for
one week, the lung contained 0.76 mg quartz or 0.44 mg T10 2 . Information compiled by Boggs
(1992) and Lai (1992) shows that minute respiratory volumes (MRV) of a 300-g rat, a 35-g mouse
and a 20-g mouse were 0.210, 0.040 and 0.025 L/min, respectively. The MRV of mice (average 25
g) in our study would be about 0.030 L/min. If it is assumed that dust deposition in the lung is
roughly proportional to the MRV of the exposed animals and if Henderson et al. (1995) had
included mice (ca. 25 g) in their study, the dust burden in the mouse lung would be about 0.1 1 mg
quartz or 0.06 mg TiO2 . In the present mouse study, a single dose of 0.1 mg or 1 mg per mouse was
chosen as low or high dose, respectively.
Bermudez et al. (2000), reported that the lung burden (determined at the end of the last exposure) in
mice exposed to T102 at 10, 50, or 250 mg/m 3
 for 13 weeks (6 h/d, 5d/wk) was 5.2, 53.5 or 170.2
mg/g of dry lung tissue. The corresponding values for lung burden of T10 2
 per mouse calculated by
these authors were approximately 0.2, 2, or 13 mg. It is noteworthy that the low dose (0.1
mg/mouse) of our study fell in between the values of the lung T10 2
 burden in mice exposed to 10
Mg/M3 for 1 week (extrapolated above using Henderson's data) and 13 weeks (Bermudez et al.,
2000). The high dose (1 mg/mouse) was half the value of the body burden in mice exposed to 50
mg1m3 for 13 weeks. This information is useful for qualitative comparisons of dust exposures by
different pulmonary administrations as long as the bolus nature of the intratracheal instillation is
recognized (Driscoll et al., 2000). It should also be noted that the residual lung burden determined
at the end of the last inhalation exposure is the dynamic result from cumulative intermittent
deliveries and continuous elimination.
When the mice were intratracheally instilled 0.1-mg T10 2 particles, an increased number of
macrophages, as compared with that in the lung of saline controls, was seen 7 days after the
treatment. This increase was not visible 90 days after treatment and the lung tissue was apparently
normal. When treated with the high TiO 2
 dose (1 mg/mouse) and killed 90 days after the dust
instillation, the mice showed that particles persisted in the lung, and numerous macrophages were
present, presumably, continuous mounting defensive responses in the lungs. Tissue
histopathological manifestations were minimal. These findings were consistent with the
observations reported by Bermudez et al. (2000). In the lungs of the mice, which were exposed for
90 days to 50 mg/m 3
 (T102 lung burden of ca. 2 mg), Bermudez found increased numbers of
macrophages and neutrophils and "elevated soluble indices of inflammation." These parameters
remained elevated when examined at 26 weeks after the last exposure. The increases were not
observed in mice exposed to 10 mg/m 3
 (lung burden ca. 0.2 mg).
In the present study, the dust suspensions for bolus instillation were freshly prepared and
ultrasonicated before treatment. Despite these precautions, clumps of particles were still seen in the
lungs, especially those that received the high doses. Exposures by inhalation would be expected to
improve the distribution in the lung and minimize clump formation (Driscoll et al., 2000). For those
animals that were instilled with 0.1 mg/mouse and killed 90 days after the treatment, MSS and S102
particles, but not LSS and T102, were still visible in the lungs. This observation indicated that T10?
and LSS were easier to clear from the lungs than MSS and SiO2. However, when the animals were
given 1 mg/mouse, all four dusts were visible in the lung regardless of whether the animals were
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killed 7 or 90 days after the dust treatment. The high doses apparently overwhelmed the pulmonary
clearance mechanisms.
Results of a particle-size distribution determination conducted after the animal treatment study
showed that the respirable fraction of MSS isolated by Lovelace from the raw material had a
bimodal distribution that included 70% fine dust with a mass median diameter (MMD) of 3 µm. To
our surprise, it also contained 30% by volume of particles with diameters ranging from 30 to 400
µm with an MMD of 108 pm (Fig. 113). Ultrasonication did not significantly alter the particle size
distribution. The reasons for the presence of these large particles in the sample prepared as
respirable dust are not known. The LSS, without ultrasonication, contained 5% large particles with
an MMD of 81 µm; upon ultrasonication for 240 seconds, all these large particles disappeared (Fig.
IA). The sonicated LSS showed a bimodal distribution with MMDs in the respirable range. In
general, the toxic insults to the lung from particles per unit weight decrease with an increase of
particle size. The presence of large particles would quantitatively, but not qualitatively, influence
the dose response. However, large particles are more persistent in the lung and therefore this fact
may partially explain why MSS was more persistent than LSS in the lung.
LSS was more toxicologically reactive than TiO ,, in the mice; the difference was more evident at the
high dose. Like TiO,,, LSS at the low dose produced very little tissue response. At the high dose,
acute mild to moderate inflammation of the lung tissue, was observed among the LSS-treated mice.
With the continuous irritation of the high-dose LSS dust in the lung, the acute inflammation, which
was observed in the 7-d group, was transformed into chronic inflammation 90 days after dust
treatment. However, the inflammatory manifestations were relatively mild with this dust.
MSS elicited a more severe reaction than the LSS. Inflammatory responses, which were not seen
in animals of the LSS-LD groups, were detected in both the MSS-LD-7d and MSS-LD-90d groups.
The inflammatory reactions, which were mild in the MSS-LD-7d group, were mild to moderate in
the lung of the MS-HD-7d group. Fibrosis was observed in the MSS-HD-90d group.
Ozone pretreatment followed by MSS instillation was used to emulate the oxidative and reactive
nature of actual Martial soil. As expected, mice receiving such treatment showed a greater
pulmonary toxicity response than those receiving either compound alone; the toxic manifestations
were especially discernible in ozone-pretreated animals instilled with the high-dose MSS. The
03+MSS-HD-7d group revealed moderate pulmonary reactions with early focal moderate to severe
fibrosis. The animals in the 90-d study had widespread intraalveolar debris, moderate alveolitis, and
fibrosis. It is noteworthy that the ozone exposure (0.5 ppm for 3 hr) alone produced no overt lung
injury when examined 7 days after- the exposure, but focal mild alveolitis and peribronchiolar
inflammation were noted 90 days after the exposure. The effects of ozone and MSS together
appeared to be additive. Nevertheless, these effects were less severe than those seen in animal
treated with high dose crystalline silica.
The pulmonary toxicity of the Hawaiian and San Francisco Mountain volcanic ashes have not been
reported. However, fibrogenic activity or other pulmonary toxicity of volcanic ashes obtained from
other locations (mostly from Mt. St. Helens) has been widely reported (Beck et al., 1981; Green et
al., 1981; Schreider et al., 1985). Green et al. (1981) reported that victims died 10-16 days after the
Mt. St. Helens eruption and autopsy revealed fibrosis in the lungs. The ash-induced fibrogenic
responses were confirmed in rats intratracheally instilled with the ash (Green et al., 1981).
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In the 1970s NASA conducted limited toxicity investigations on lunar soil samples.
Intraperitoneal and subcutaneous injections of the lunar soil to mice resulted in acute
inflammatory responses throughout the peritoneum or surrounding the subcutaneous injection
site, respectively. Low-grade inflammatory reactions but no fibroblastic lesions were detected
20 months after the injection. Intratracheal injections of the lunar soil into guinea pigs were also
carried out on three groups of 4 guinea pigs given 2 ml of saline containing 2% dust or no dust
(3 dust-treated and only 1 saline control) (Holland and Simmonds, 1972). Two of the groups
were killed on either 2 or 4 days after the injection. No information was given on exactly when
the third group, which was held for long-term observation, was killed. Without referring to
which group(s), the authors reported that a diffuse alveolar cell hypertrophy, septal edema,
monuclear infiltration, and proliferation of alveolar macrophages were observed. The authors
stated that "the tissue response seemed out of proportion to the amount of particle material
present." Unable to discern the treatment effects because of a significant degree of spontaneous
pulmonary pathology in both control and dust-treated guinea pigs, the authors concluded "the
potentially harmful or innocuous nature of the dust remains to be investigated."
The Russians also conducted a series of studies to determine the toxicity of lunar soil they
collected. A study was conducted ill 	 exposed to air (0.5 L/min) which was "passed
through a layer" of preweighed sample of lunar surface material for 4 days (4 hr/d) (Kustov et
al., 1974). According to the authors, pathomorphological examinations of internal organs
showed no differences between the treated mice and controls exposed to clean air.
Unfortunately, no information was presented on any weight loss after the air passed through the
test material. Moreover, the authors also did not specify whether the lung was included in the
examination.
Another Russian study (Kustov et al. 1989) was conducted in Wistar rats each injected
intratracheally with a single dose of 50 mg (in 1% starch solution) lunar dust, or terrestrial analog (a
basalt from Kamchatka, Russia). The compositions of the Russian lunar soil and terrestrial analog
are comparable to U.S. counterparts. Six months after the dust treatment, the lung tissue revealed
many fibrous cellular nodes that contained dust particles, macrophages, lymphocytes, plasmocytes,
fibroblasts, and giant multinuclear cells. Terrestrial analog, like the extraterrestrial counterpart, also
produced pneumoconiosis characterized by the development of fibrous cellular nodes, pronounced
interstitial fibrosis and interlobular septa. These results are expected due to the massive dust dose
used in these rats by the Russian investigators. Bermudez et al. (2000) reported that 13-week
exposures (6 h/d, 5d/wk) of rats to 250 mg/m 3 T102, a dust that at low concentrations produced little
effects in rats, resulted in hypertrophy and hyperplasia of alveolar epithelium, and fibrotic changes;
these effects were not seen in rats exposed to 50 mg/m 3 TiO2
 and in mice exposed to either
concentration. The lung burden of dust in rats exposed to 250 or 50 mg/m 3 TiO2
 determined at the
end of the exposures was 40 or 8 mg/rat, respectively. The dose of 50 mg/rat in the Russian study
apparently seriously overloaded the lungs of the rats. It is well known that greatly overloading dust
in rats impairs cellular responses to clear and sequester particles leading to a spectrum of
histopathology that could include cancer (Next, 1994; Morrow, 1992; Muhle et al., 1990;
Trochimowicz, 1988).
(Kustov et al., 1989) also stated that the interaction of lunar soil and pulmonary tissue was
accompanied by cellular autoimmune reactions. Unfortunately, experimental procedures to assess
cellular autoimmunity, as well as the results to support the authors' interpretation were not
presented. Therefore, a study is needed to determine whether lunar soil can induce cellular
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autoimmune reaction. The need is further supported by findings implicating silica, a fibrogenic dust,
in the induction of various autoimmune disorders (McHugh et al., 1994). In the present study, the
ability of LSS and the other dusts to elicit production of antinuclear antibodies in mice was
assessed. The results (Fig. 6) showed that silica and LSS dust were capable of increasing ANA; the
increase was statistically significant only for the high-dosed silica and low-dosed LSS groups. This
result suggests the possibility that LSS could induce cellular autoimmunity. However, the
implications of this result are confounded by the apparent lack of a dose-response relationship.
Moreover, in humans, ANA test is only an important adjunct for diagnosis of autoimmune diseases
(Fritzler, 1986), other medical diagnostic tests are needed for disease prognosis because a
considerable number of healthy persons also showed positive results on ANA (Tan et al., 1997;
Kavanaugh, 1999).
The overall results of the present study showed that LSS and MSS are not simply nuisance dusts.
It is reasonable to predict that inhalation exposures to LSS or MSS would produce more pulmonary
responses than exposures to TiO-,, but less severe responses than crystalline SiO-,. Even though the
chemical compositions of these dust simulants are similar to lunar or Martian soil, the results of the
present study on the simulants would be no more than qualitative indicators of the hazards of the
extraterrestrial soils. The results of the co-exposures to ozone and MSS suggest that Martian soil, a
dust with a reactive surface and probably persistent in the lung like MSS if it is inhaled, could
produce more severe injury than that caused by the simulant. These findings support NASA's
intention to evaluate the oxidative and reactive Martian surface soil before sending humans to the
hostile Martian environment (Sullivan, 2000, personal communication).
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FIG. 2 Lung histopathology of mice intratracheally instilled with a single dose of 0.1 mg (LD) or I mg
(HD) of T102 (A, B) or quartz (C. D). The animals were killed 90 days after the dust treatment. The lung
histology of mice in the TiO2 -LD-90d (A) was indistinguishable from that of saline controls, therefore,
Fig. A is also used to illustrate normal lung histology. In the figures, ad = alveolar duct, b = bronchus, v
vessel; in (13):	 = focal mild perivascular inflammation, 	 )0- = clumps of particles; (C) shows mild
focal fibrosis,	 )o = mild perivascular and pci-ibronchiolar inflammation; (D) shows moderate
alveolitis, severe focal fibrosis,	 moderate to severe perivascular and pen'bronchiolaF inflammation,
intraalveolar debris and edema.
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FIG. 3. Lung histopathology of mice intratracheally instilled with a single dose of 0.1 mg (A. B) or 1 mg
(C, D) of lunar soil simulant and killed 7 days (A, C) or 90 days (B, D) after the treatment. In the figures, ad
= alveolar duct, b = bronchus, v = vessel. in (A): )10 = particle-laden macro-phages; (B) shows no parti-
cles and normal tissue; (C) shows mild to moderate alveolitis with lymphocyte and neutrophile infiltration,
- )0= alveolar damage, particle-laden macrophages, inflammatory cells; (D) shows mild alveolitis,
)= septal thickening, blood vessel and hronchial inflammation.
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(C,D)of Martian soil simu\ani and killed 7 days (A ' Q0r90 days (B and 0 after the dust treatment. In
the figures, ad alveolar duct. b = bronchus, v = vessel; (A) shows inflammation cells and scattered debris:
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FIG. 5. Lun g histopathology of ozone-pretreated mice each was intratracheally instilled with a single dose
of 0.1 mg (A. B) or I mg (C, D) of Martian soil simulant and killed 7 days (A, C) or 90 days (B, D) after the
dust treatment. The ozone exposure was 3 h at 0.5 ppm. In the figures. av = alveolar duct, b = bronchus,
v = vessel; in (A): --> = peribronchial inflammation. --)o-= focal inflammation: in (B): --)0- = focal
inflammation and fibrosis; in (C): 	 focal inflammation, alveolitis, and intraalveolar debris; in (D):
--)P-= septal thickening, fibrosis, wide-spread intraalveolar debris and alveolitis.
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FIG. 6. Comparison of antinuclear antibody fluorescence intensity in serum of mice each was
intratracheally instilled with 0 (saline only), 0. 1, or 1 mg of Martian soil simulant, lunar soil
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FIG. 7. Comparison of antinuclear antibody fluorescence intensity in serurn of ozone-pretreated
mice each was intratracheally 0 (saline only), 0. 1, or 1 mg Martian soil simulant. Instillation was
preceded by a 3-h exposure to 0.5 ppm ozone. Serum samples were collected 90 days after the
treatment. Each bar represents the mean (±SD) from 4 mice (* = statistical difference from that of
ozone-preexposed mice treated with saline, p5 0.05).
19
^	 ^	 1
REFERENCES
Allen C., Morris, R.V., Jager, K.M., Golden, D.C., Lindstrom, D.J., Lindstrom, M.M., and
Lockwood, J. P. (1998). JSC Mars-1: a Martian soil simulant. Space 98 Proceeding of the
Conference ofAmerican Society of Civil Engineers 469-475. April 26-30, Albuquerque,
NM.
Belkin, V.I., Kustov, V.V., Kulakova, M.K., and Panchenkova, E.F. (1983). [Biological activity
of lunar soil from the Sea of Fertility (Marc Fecunditatis) when injected intratracheally].
Serilia Biologicheskaia 3, 461-465.
Beck, B.D., Brian, J.D. and Bohannon D.E. (1981). The pulmonary toxicity of an ash sample
from the Mt St. Helens Volcano. Experimental Lung Research 2, 289-301.
Bermudez, E., Magum, J. B., Reverdy, E. E., Wong, B. A., Asgharian, B., Hext, P. M., Warheit,
D. B., and Everitt, J. I. (2000). Pulmonary responses of rats, mice, and hamsters to inhaled
titanium dioxide (TiO2). Toxicol. Sci. 54, 314.
Benschoter, C. A., Allison, T.C., Boyd, J. F., Brooks, M. A., Campbell, J. W., Groves, R. 0.,
Heimpel, A. M., Mills, H. E., Ray, S. M., Warren, J., W., Wolf, K. E., Wood, E. M., Wrenn,
R. T., and Zein-Eldin, Z. (1970). Apollo 11: exposure of lower animals to lunar material.
Science 169, 470-472.
Boggs D. F. (1992). Comparative control of respiration. In: Treatise on Pulmonary Toxicology,
Vol. I: Comparative Biology of the Normal Lung, 309-350. Ed. R. A. Parent. CRC Press,
Boca Raton, FL.
Driscoll K. E., Costa, D. L., Hatch, G., Henderson, R., Oberdorster, G., Salem, H., and
Schlesinger, R. B. (2000). Intratracheal instillation as an exposure technique for the
evaluation of respiratory tract toxicity: uses and limitations. Toxicol. Sci. 55, 24-35.
Fritzler M J, and Tan E M. (1985) Antinuclear Antibodies and the Connective Tissue
Diseases. In: Laboratory Diagnostic Procedures in the Rheumatic Diseases, 3rd ed. (A.S.
Cohen, Ed.), Chapter 8. pp. 207-247, Grune and Stratton, NY.
Fritzler, M. J. (1986). Autoantibody testing: procedures and significance in systemic rheumatic
diseases. Methods Achiev Exp Pathol. 12, 224-260
Glaser, P.E. (1992). Mitigation of dust contamination during EVA operations on the moon and
Mars. In: Engineering, construction, and Operations in Space, III: Space'92: Proceedings
of the 3rd International Conference.
Green, F., Vallyathan, V., Mentech, M., Tucker, J., Merchant, J., Kiessling, P., Antonius, J., and
Parshey, P. (1981). Is volcanic ash a pneumoconiosis risk? Nature 293, 216-217.
Henderson, R. F., Driscoll, K. E., Harkema J. R., Linderschmidt, R. C., Chang, I.-Y., Maples, K.
R., and Barr, E. B. (1995). A comparison of the inflammatory response of the lung to
inhaled versus instilled particles in F344 Rats. Fundam. Appl. Toxicol. 24, 183-197.
20
1
t	 +t	 }
i
Hext, P. M. (1994). Current perspectives on particulate induced pulmonary tumours. Hum Exp
Toxicol. 13, 700-715.
Hoffman, S. and Kaplan, D. (1997). Human Exploration of Mars: The Reference Mission of the
NASA Mars Exploration Study Team. NASA Special Publication 61-7, NASA Center for
Aerospace Information, Linthicum Heights, MD.
Holland J.M. and Simmonds, R.C. (1972). The mammalian response to lunar particulates.
Space Life Sciences, 4(1), 97-109.
Kavanaugh, A. (1999). The role of the laboratory in the evaluation of rheumatic diseases.
Clinical Cornerstone 2(2): 11-21.
Kustov, V.V., Ostapvenko, O.F., and Petrukhin, V.G. (1974). [Research on the biological effect
of a fine fraction of lunar soil sent to Earth by the unmanned station Luna-16]. In: [Lunar
Soil From the Sea of Fertility] (Nauka, M., ed). P. 592.
Kustov, V.V., Belkin, V.I., and Kruglikov, G.G. (1989). [Biological effects of lunar soil].
[Problems in Space Biology] 61,1 -146.
Kirichenko, A., Li, L., Morandi, M. T., and Holian, A. (1996). 4-Hydroxyl-2-nonenal-protein
adducts and apoptosis in murine lung cells after acute ozone exposure. Toxicol. Appl.
Pharmacol. 141,416-424.
Lai, Y.-L. (1992). Comparative ventilation of the normal lung. In: Treatise on Pulmonary
Toxicology, Vol. P Comparative Biology of'the Normal Lung (R. A. Parent, ed.), 217-239.
CRC Press, Boca Raton, FL.
McHugh, N. J., Whyte, J, Harvey, G., and Haustein, U. F. (1994). Anti-topoisomerase I
antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis
Rheum. 37 (8), 1198-1205.
McKay, D.S., Carter, J.L. Boles, WW, Allen, C.C., and Allton, J.H. JSC-1: a new lunar soil
simulant. Proceedings of Space '94, Conference of American Society of Civil Engineers,
February 26 - March 3, 1994, Albuquerque, NM
Morrow, P. E. (1992). Dust Overloading of the Lungs: Update and Appraisal. Toxicol. Appl.
Pharmacol. 113, 1 -12.
Muhle, H., Bellmann B., Creutzenberg, O., Heinrich, U., Ketkar, M., and Mermelstein. R
(1990). Dust Overloading of Lungs after Exposure of Rats to Particles of Low Solubility:
Comparative Studies. J. Aerosol Sci. 21, 374-377.
NASA (1969). Appolo 11 Technical Crew Debriefing. Houston, TX.. Cited in Final Report:
Dust Control and Protection for Planetary Exposure. Prepared by Lockheed Engineering &
Sciences Company. NASA Document JSC-25975, National Aeronautics and Space
Administration, Johnson Space Center, Houston., TX
21
i
w
NASA (1970). Apollo 12 Preliminary Science Report. NASA SP-235, Scientific and Technical
Information, Division, Office of Technology Utilization, National Aeronautics and Space
Administration, Washington, D.C.
Oyama V. I. and Berdahl B.J. (1977). The Viking gas exchange experiment results from Chryse
and Utopia surface samples. J. Geophysical Research 82, 4669-4676.
Simmonds R.C., Holland, J.M., Young, E.L., and Boyd, M.S. (1972). Animal maintenance for
biomedical evaluation of lunar material. J. Am. Vet. Med. Assoc. 161: 720-727.
Schreider J.P., Culbertson, M.R., and Raabe, O.G. (1985). Comparative pulmonary fibrogenic
potential of selected particles. Environ. Res. 38, 256-274.
Smith, W. B., Wilson, R. R., and Harris, D. B. (1979). A five-stage cyclone system for in situ
sampling. Environ. Sci. Technol. 13,1387-1392.
Tan, E.M., Feltkamp, T. E., Smolen, J. S., Butcher, B., Dawkins, R., Fritzler, M. J., Gordon, T.,
Hardin, J. A., Kalden, J. R., Lahita, R. G., Maini, R. N., McDougal, J. S., Rothfield, N. F.,
Smeenk, R. J., Takasaki, Y., Wiik, A., Wilson, M. R., and Koziol, J. A. (1997) . Range of
antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 40.1601-161 1.
Taylor- G.R., Simmonds, R.C., and Walkinshaw, C.H. (1975). Quarantine testing and
biocharacterization of lunar materials. In: Biomedical Results of Apollo (R S. Johnston, L.
F. Dietlein, and C.A. Berry, eds.), 425- 434. National Aeronautics and Space
Administration, Washington, D.C.
Trochimowicz, H. J., Lee, K. P., and Reinhardt, C. F. (1988). Chronic inhalation exposure of rats
to titanium dioxide dust. J. Appl. Toxicol. 8, 383-385.
Tsapin, A.I., Goldeld, M.G., McDonald, G.D., Nealson, K.H., Moscowitz, B., Solheid, P.,
Kemner, K.H., Kelly, S.D., and Orlandini, K.A. (2000). Iron (VI): Hypothetical candidate for
the Martian Oxidant, Icarus, 147, 68-79.
22
